Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Juergen Rech is currently the head of clinical trial unit at University of Erlangen-Nuremberg, Germany.He also served as senior consultant in department of Rheumatology and Immunology at University of Erlangen-Nuremberg.
Rheumatology, Immunology, Oncology.
Effects of Concomitant Conventional and Previous Biological Disease Modifying Anti-Rheumatic Drugs Treatment on the Efficacy of Tocilizumab to Induce Remission in Patients with Rheumatoid Arthritis An Observational Real-Life Study
Kathrin Standfest, Matthias Englbrecht, Klaus Krueger, Wolfgang Ochs, Matthias Schmitt- Haendle, Herbert Kellner, Hans-Peter Tony, Stefan Kleinert, Martin Feuchtenberger, Florian Schuch, Jörg Wendler, Hendrik Schulze- Koops, Mathias Grünke, Matthias Witt, Martin Fleck, Jochen Zwerina, Karin Manger, Bernhard Manger, Georg Schett, Axel J Hueber and Juergen Rech
Research Article: Rheumatology (Sunnyvale) 2015, 1000157